# Transitioning From Cyclosporine to Alefacept in Psoriasis

> **NCT00143806** · PHASE2 · COMPLETED · sponsor: **University of Medicine and Dentistry of New Jersey** · enrollment: 13 (—)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** Transitioning patients from cyclosporine to alefacept

## Key facts

- **NCT ID:** NCT00143806
- **Lead sponsor:** University of Medicine and Dentistry of New Jersey
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10
- **Primary completion:** —
- **Final completion:** 2007-05
- **Target enrollment:** 13 (—)
- **Last updated:** 2009-01-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00143806

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00143806, "Transitioning From Cyclosporine to Alefacept in Psoriasis". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00143806. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*